---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-25-000362"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:21:24.544592+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Health authorizes new $250M share repurchase program; prior $100M fully used

## Summary
- New $250M share repurchase program authorized by Board on Nov 13, 2025, expiring Nov 11, 2028.
- From Oct 1 to Nov 7, 2025, repurchased 1,334,572 shares for $55.5M, exhausting prior $100M program.
- Repurchases may be made via open market, private negotiations, or Rule 10b5-1 plans; program may be suspended or discontinued.
- New authorization increases buyback capacity by 2.5x compared to the prior $100M program.

## SEC filing metadata
- accession: 0001773751-25-000362
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000362/0001773751-25-000362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000362/hims-20251113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-25-000362
- JSON: https://secwatch.observer/filing/0001773751-25-000362.json
- Plain text: https://secwatch.observer/filing/0001773751-25-000362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.